title: Foreign body granuloma at the exit site in patients on CAPD: use of 1% gentian violet as topical treatment.
authors.affiliation: Nephrology Division, São Francisco Hospital, Ribeirão Preto, SP, Brazil.
authors.forename: M
authors.initials: M
authors.lastname: Moysés-Neto
authors.forename: A
authors.initials: A
authors.lastname: Cherubini
authors.forename: M E
authors.initials: ME
authors.lastname: Batista
authors.forename: E O
authors.initials: EO
authors.lastname: Raspanti
authors.forename: O M
authors.initials: OM
authors.lastname: Vieira-Neto
authors.forename: B
authors.initials: B
authors.lastname: Nakagawa
authors.forename: A M
authors.initials: AM
authors.lastname: Conceição
authors.forename: M R
authors.initials: MR
authors.lastname: Feres
authors.forename: M T
authors.initials: MT
authors.lastname: Vannucchi
mesh_terms: D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D002408:Catheters, Indwelling / Q000009:adverse effects*; D005840:Gentian Violet / Q000008:administration & dosage*; D015745:Granuloma, Foreign-Body / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*
chemical_list: D000891:Anti-Infective Agents, Local; D005840:Gentian Violet